Judge Lets Dana-Farber Advance Cancer Drug IP Suit
A Massachusetts federal judge has found that the Dana-Farber Cancer Institute made a plausible argument asserting that it is entitled to damages after Bristol-Myers Squibb left the research center's name off...To view the full article, register now.
Already a subscriber? Click here to view full article